A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The Connection Study is a six-month confirmatory Phase 3 study to determine the safety and
efficacy of Dimebon in the treatment of mild-to-moderate Alzheimer's disease (AD).